Scarica l'app Stockscreener
609.67
1.20%
6.4918
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$603.18
Aprire:
$609.96
Volume 24 ore:
187.88K
Relative Volume:
0.10
Capitalizzazione di mercato:
$225.46B
Reddito:
$45.20B
Utile/perdita netta:
$6.87B
Rapporto P/E:
33.52
EPS:
18.1888
Flusso di cassa netto:
$6.75B
1 W Prestazione:
-0.55%
1M Prestazione:
+0.90%
6M Prestazione:
+23.14%
1 anno Prestazione:
+24.22%
Intervallo 1D:
$606.15
$611.51
Intervallo di 1 settimana:
$594.82
$611.51
Portata 52W:
$435.27
$647.00
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, NTRA, IQV, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
609.78 | 223.02B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
200.31 | 140.97B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
326.38 | 47.01B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
258.65 | 42.35B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
145.12 | 40.35B | 7.23B | 1.41B | 1.09B | 4.979 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-27 | Iniziato | DZ Bank | Buy |
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-12-01 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Thermo Fisher Scientific Share Price Today (TMO) | Live Chart, News & Stock Market - TechGraph
Thermo Fisher Drew Two Upgrades Near Its Highs. Here’s Where the Stock Could Go - tikr.com
Thermo Fisher stock gains analyst support as UBS lifts target to 730 dollars - ad-hoc-news.de
Thermo Fisher, Wells Fargo, Nutrien And More On CNBC’s ‘Final Trades’ - Benzinga
Thermo Fisher stock heads into the open after a 0.4% loss - ad-hoc-news.de
UBS Upgrades Thermo Fisher Scientific to Buy From Neutral, Adjusts Price Target to $730 From $540 - Moomoo
Thermo Fisher, Danaher Could Log Mid-Single-Digit Organic Revenue Growth in 2027, UBS Says - Yahoo Finance
UBS upgrades Thermo Fisher Scientific stock rating on growth outlook By Investing.com - Investing.com Canada
Thermo Fisher stock slips as dividend date nears - ad-hoc-news.de
Thermo Fisher stock heads into the open after a 1.75 percent drop - AD HOC NEWS
Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market - MarketWatch
If You Invested $1000 In Thermo Fisher Scientific Stock 15 Years Ago, You Would Have This Much Today - Benzinga
Thermo Fisher (NYSE:TMO): Can New Products Justify Its Valuation? - Kalkine Media
Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others - Yahoo Finance UK
Take the Zacks Approach to Beat the Markets: Oportun Financial, Uranium Royalty & Amgen in Focus - Zacks Investment Research
IVD Raw Material Market Report Now Available — Forecasts Market Growth from $21.5B (2026) to $31.1B by 2031, Profiling Merck KGaA, Thermo Fisher, Bio-Techne, Fapon Biotech, and 21 Other Key Players - uk.finance.yahoo.com
Thermo Fisher stock heads into the open after a modest recent gain - ad-hoc-news.de
Thermo Fisher stock holds steady after solid mid-year results - AD HOC NEWS
Thermo Fisher Scientific (NYSE:TMO): Can Demand Outweigh Macro Risks? - Kalkine Media
Is Thermo Fisher Scientific (NYSE:TMO) Ready for Another Breakout? - Kalkine Media
Thermo Fisher Scientific Inc. (TMO) Stock Analysis: A Leading Healthcare Giant with Strong Revenue Growth Prospects - DirectorsTalk Interviews
Thermo Fisher Scientific (NYSE:TMO) Shows Strong Technical Breakout Setup - ChartMill
Thermo Fisher CEO: ‘Society broadly embraces the breakthroughs’ - Financial Times
Thermo Fisher stock trades near consensus target as guidance supports outlook - AD HOC NEWS
How Thermo Fisher’s New Workflow-Focused Lab Instruments At Thermo Fisher Scientific (TMO) Has Changed Its Investment Story - webull.com
Should You Continue to Hold TMO Stock in Your Portfolio? - TradingView
Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Baird Adjusts Price Target on Thermo Fisher Scientific to $686 From $652, Keeps Outperform Rating - marketscreener.com
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Thermo Fisher Scientific Launches Multiskan™ Ease Absorbance Microplate Reader to Help Simplify Protein, Cell and Microbial Analysis - Business Wire
Thermo Fisher (NYSE: TMO) insider uses stock to cover taxes instead of selling on market - Stock Titan
Thermo Fisher (NYSE: TMO) CAO has 49.899 shares withheld to cover tax or exercise costs - Stock Titan
Thermo Fisher Scientific (NYSE: TMO) CEO uses shares to cover taxes and discloses trust holdings - Stock Titan
Thermo Fisher (NYSE: TMO) HR chief uses 394 shares to cover exercise price or tax liability - Stock Titan
Equity award costs paid in stock at Thermo Fisher (TMO) - Stock Titan
Thermo Fisher Scientific to Present at the Morgan Stanley 24 - Business Wire
Thermo Fisher Scientific (TMO) Unveils New Tools For Electron Microscopy And Isotope Analysis - Yahoo Finance
Thermo Fisher (NYSE: TMO) executive to sell 4,133 shares - Stock Titan
Is Thermo Fisher Scientific Stock Outperforming the Nasdaq? - Barchart.com
Thermo Fisher Scientific Inc. (TMO): Investor Outlook with a 1.49% Potential Upside and Strong Buy Ratings - DirectorsTalk Interviews
Thermo Fisher Scientific Inc. stock falls Friday, underperforms market - MarketWatch
Thermo Fisher Scientific Introduces the Thermo Scientific™ EMPAD™ G2 Electron Detector to Advance Materials Research - BioSpace
Thermo Fisher (NYSE: TMO) CEO exercises options, sells 275 shares - Stock Titan
Thermo Fisher Scientific Launches First Orbitrap Mass Spectrometers for Isotope Ratio Analysis, Enabling More Labs to Decode the Story Behind a Sample - BioSpace
Thermo Fisher (NYSE: TMO) CEO lines up new sale after $6M August trades - Stock Titan
Thermo Fisher Scientific (TMO) Stock Fair Value Rises After Q2 Strength And Analyst Revisions - Yahoo Finance
Thermo Fisher (NYSE: TMO) holder Marc Casper plans another stock sale - Stock Titan
Portfolio Design Labs LLC Takes $1.53 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
4,241 Shares in Thermo Fisher Scientific Inc. $TMO Acquired by Silvant Capital Management LLC - MarketBeat
Trillium Asset Management LLC Purchases Shares of 31,849 Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):